Literature DB >> 26628457

Metal coverage ratio of pipeline embolization device for treatment of unruptured aneurysms: Reality check.

Liang-Der Jou1, Gouthami Chintalapani2, Michel E Mawad3.   

Abstract

BACKGROUND AND
PURPOSE: The metal coverage ratio (MCR) of a flow diverter influences the intra-aneurysmal hemodynamics; a high MCR will occlude an aneurysm early, while a low MCR may delay aneurysm occlusion. The true MCR of a pipeline embolization device (PED) could be lower due to oversize, device deformation, or aneurysm location. In this study deviation of the true MCR from the nominal MCR is assessed and whether their difference affects aneurysm occlusion rate is determined.
METHODS: A total of 40 consecutive patients, each of them treated by one PED for their aneurysms at the internal carotid artery (ICA), were retrospectively analyzed. The DynaCT images of these deployed PEDs were used to determine their true dimensions and estimate three MCRs (local, mean, and nominal). These data were compared in two groups of patients who had different aneurysm outcomes at six months.
RESULTS: The difference in the local MCR between two groups is small, but statistically significant (24.5% vs 21.6%, p=05). The local MCR is consistently lower than the nominal MCRs (23.2% vs 30.2%, p<0.001); however, the difference between the mean and local MCRs is small (23.9% vs 23.2%).
CONCLUSIONS: An expectation that a PED can achieve a MCR of 30% may not be reasonable. Device oversize and deformation during deployment lower the local MCR by 5-7%. A lowered MCR affects the aneurysm occlusion rate at six months.
© The Author(s) 2015.

Entities:  

Keywords:  Aneurysms; flow diverter; subarachnoid hemorrhage

Mesh:

Substances:

Year:  2015        PMID: 26628457      PMCID: PMC4757378          DOI: 10.1177/1591019915617315

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  31 in total

1.  Coiling for paraclinoid aneurysms: time to make way for flow diverters?

Authors:  P I D'Urso; H H Karadeli; D F Kallmes; H J Cloft; G Lanzino
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-08       Impact factor: 3.825

2.  Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment.

Authors:  Z Kulcsár; E Houdart; A Bonafé; G Parker; J Millar; A J P Goddard; S Renowden; G Gál; B Turowski; K Mitchell; F Gray; M Rodriguez; R van den Berg; A Gruber; H Desal; I Wanke; D A Rüfenacht
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-11       Impact factor: 3.825

3.  Ophthalmic artery occlusion immediately following placement of a flow diverter without clinical sequelae.

Authors:  Justin R Mascitelli; Margaret Pain; Fedor Panov; Joshua B Bederson; Aman B Patel
Journal:  Interv Neuroradiol       Date:  2015-05-01       Impact factor: 1.610

4.  Actual metal coverage at the neck is critical for flow-diverting stents in treating intracranial aneurysms.

Authors:  K Wang; S Yuan
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-28       Impact factor: 3.825

5.  Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results.

Authors:  I Saatci; K Yavuz; C Ozer; S Geyik; H S Cekirge
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-19       Impact factor: 3.825

6.  Endovascular treatment of ophthalmic artery aneurysms: ophthalmic artery patency following flow diversion versus coil embolization.

Authors:  Christopher R Durst; Robert M Starke; David Clopton; H Robert Hixson; Paul J Schmitt; Jean M Gingras; Dale Ding; Kenneth C Liu; R Webster Crowley; Mary E Jensen; Avery J Evans; John Gaughen
Journal:  J Neurointerv Surg       Date:  2015-09-09       Impact factor: 5.836

7.  The pipeline embolization device for the intracranial treatment of aneurysms trial.

Authors:  P K Nelson; P Lylyk; I Szikora; S G Wetzel; I Wanke; D Fiorella
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-09       Impact factor: 3.825

8.  Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device.

Authors:  I Szikora; Z Berentei; Z Kulcsar; M Marosfoi; Z S Vajda; W Lee; A Berez; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-11       Impact factor: 3.825

9.  Fate of the Ophthalmic Artery After Treatment With the Pipeline Embolization Device.

Authors:  Nohra Chalouhi; Badih Daou; David Kung; Mario Zanaty; Jessica L Phillips; Stavropoula Tjoumakaris; Robert M Starke; David Hasan; Adam Polifka; Sussan Salas; Robert H Rosenwasser; Pascal M Jabbour
Journal:  Neurosurgery       Date:  2015-10       Impact factor: 4.654

10.  Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience.

Authors:  Pedro Lylyk; Carlos Miranda; Rosana Ceratto; Angel Ferrario; Esteban Scrivano; Hugh Ramirez Luna; Aaron L Berez; Quang Tran; Peter K Nelson; David Fiorella
Journal:  Neurosurgery       Date:  2009-04       Impact factor: 4.654

View more
  8 in total

Review 1.  On Flow Diversion: The Changing Landscape of Intracerebral Aneurysm Management.

Authors:  A A Dmytriw; K Phan; J M Moore; V M Pereira; T Krings; A J Thomas
Journal:  AJNR Am J Neuroradiol       Date:  2019-03-20       Impact factor: 3.825

2.  In vitro digital subtraction angiographic evaluation of flow diverters in a patient-specific aneurysm.

Authors:  Liang-Der Jou
Journal:  Interv Neuroradiol       Date:  2017-01-01       Impact factor: 1.610

Review 3.  Surpass Evolve Flow Diverter for the Treatment of Intracranial Aneurysm: A Systematic Review.

Authors:  Rania Issa; Zahrah Al-Homedi; Dawood Hasan Syed; Waseem Aziz; Basem Al-Omari
Journal:  Brain Sci       Date:  2022-06-20

4.  Toward Better Understanding of Flow Diversion in Bifurcation Aneurysms.

Authors:  M Shapiro; A Shapiro; E Raz; T Becske; H Riina; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2018-11-15       Impact factor: 3.825

5.  In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials.

Authors:  Ali Sarrami-Foroushani; Toni Lassila; Michael MacRaild; Joshua Asquith; Kit C B Roes; James V Byrne; Alejandro F Frangi
Journal:  Nat Commun       Date:  2021-06-23       Impact factor: 14.919

6.  Neck Location on the Outer Convexity is a Predictor of Incomplete Occlusion in Treatment with the Pipeline Embolization Device: Clinical and Angiographic Outcomes.

Authors:  T Sunohara; H Imamura; M Goto; R Fukumitsu; S Matsumoto; N Fukui; Y Oomura; T Akiyama; T Fukuda; K Go; S Kajiura; M Shigeyasu; K Asakura; R Horii; C Sakai; N Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-12       Impact factor: 3.825

7.  Comparison of intra-aneurysmal flow modification using optical flow imaging to evaluate the performance of Evolve and Pipeline flow diverting stents.

Authors:  Nicole Mariantonia Cancelliere; Patrick Nicholson; Ivan Radovanovic; Karla Mirella Mendes; Emanuele Orru; Timo Krings; Vitor M Pereira
Journal:  J Neurointerv Surg       Date:  2020-04-21       Impact factor: 5.836

8.  Hydrodynamic Resistance of Intracranial Flow-Diverter Stents: Measurement Description and Data Evaluation.

Authors:  Benjamin Csippa; Dániel Gyürki; Gábor Závodszky; István Szikora; György Paál
Journal:  Cardiovasc Eng Technol       Date:  2019-12-03       Impact factor: 2.495

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.